Research-Based Clinical Strategies to Prevent and Address Adolescent Substance Use and Prescription Medication Misuse- Being Part of the Solution Part 2 of 2

References

Ali S, Mouton CP, Jabeen S, et al. Early detection of illicit drug use in teenagers. InnovClinNeurosci. 2011;8(12):24-28.

American Academy of Pediatrics. ADHD: clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Pediatrics. 2011;128(4):1007–1022. doi:10.1542/peds.2011-2654.

American Psychiatric Association (APA). Diagnostic and Statistical Manual of Mental Disorders. 5th ed. Arlington, VA: APA; 2013.

Berg CJ, Stratton E, Schauer GL, et al. Perceived harm, addictiveness, and social acceptability of tobacco products and marijuana among young adults: marijuana, hookah, and electronic cigarettes win. Subst Use Misuse. 2015;50(1):79-89. doi:10.3109/10826084.2014.958857.

Bukstein OG, Bernet W, Arnold V, et al. Practice parameter for the assessment and treatment of children and adolescents with substance use disorders. J Am Acad Child Adolesc Psychiatry. 2005;44:609-621.

Bunnell RE, Agaku IT, Arrazola RA, et al. Intentions to smoke cigarettes among never-smoking US middle and high school electronic cigarette users: national youth tobacco survey, 2011-2013. Nicotine Tob Res. 2015;17(2):228-235. doi:10.1093/ntr/ntu166.

Carney T, Myers B. Effectiveness of early interventions for substance-using adolescents: findings from a systematic review and meta-analysis. Subst Abus Treatment, Prev, Policy. 2012;7(25). doi:10.1186/1747-597X-7-25.

Chan YF, Dennis ML, Funk RR. Prevalence and comorbidity co-occurrence of major internalizing and externalizing disorders among adolescents and adults presenting to substance abuse treatment. J Subst Abuse Treat. 2008;34:14-24.

Fiore MC, Jaen CR, Baker TB, et al. Treating Tobacco Use and Dependence: 2008 Update. Clinical Practice Guideline. Rockville, MD: U.S. Department of Health and Human Services, Public Health Service; 2008. October 13, 2016.

Fishman MJ, Winstanley EL, Curran E, Garrett S, Subramaniam G. Treatment of opioid dependence in adolescents and young adults with extended release naltrexone: preliminary case-series and feasibility. Addiction. 2010;105(9):1669-1676.

Food and Drug Administration (FDA). FDA Announces Enhanced Warnings for Immediate-Release Opioid Pain Medications Related to Risks of Misuse, Abuse, Addiction, Overdose and Death. Silver Spring, MD: FDA; 2016. Accessed August 11, 2016.

Griswold KS, Aronoff H, Kernan JB, Kahn LS. Adolescent substance use and abuse: recognition and management. Am Fam Physician. 2008;77(3):331-336.

Harris SK, Csémy L, Sherritt L, et al. Computer-facilitated substance use screening and brief advice for teens in primary care: an international trial. Pediatrics. 2012;129(6):1072-1082.

Harstad E, Levy S. Attention-deficit/hyperactivity disorder and substance use. Pediatrics. 2014;134(1):e293-e301. doi:10.1542/peds.2014-0992.

Hogue A, Liddle HA. Family-based treatment for adolescent substance abuse: controlled trials and new horizons in services research. J FamTher. 2009;31(2):126-154. doi:10.1111/j.1467-6427.2009.00459.x.

Kampman K, Jarvis M. American Society of Addiction Medicine (ASAM) national practice guideline for the use of medications in the treatment of addiction involving opioid use. J Addict Med. 2015;9:1-10. doi:10.1097/ADM.0000000000000166.

Karpinski JP, Timpe EM, Lubsch L. Smoking cessation treatment for adolescents. J PediatrPharmacolTher. 2010;15(4):249-263. doi:10.5863/1551-6776-15.4.249.

LaBotz M, Griesemer BA, AAP Council on Sports Medicine and Fitness. Use of performance-enhancing substances. Pediatrics. 2016;138(1):e20161300. doi:10.1542/peds.2016-1300.

Levy S, Shrier, L, Massachusetts Child Psychiatry Access Project. Adolescent SBIRT: Toolkit for Providers. Boston, MA: Boston Children’s Hospital; 2015. Accessed June 22, 2016.

Levy S, Williams J, Committee on Substance Use and Prevention. Substance use screening, brief intervention, and referral to treatment. Pediatrics. 2016;138(1):e1-e15. doi:10.1542/peds.2016-1211.

Levy S, Winters KC, Knight JR. Screening and brief interventions for adolescent substance abuse in the general office setting. In: Kaminer Y, Winters KC, eds. Clinical Manual of Adolescent Substance Abuse Treatment. Washington, DC: American Psychiatric Publishing; 2010:65-81.

Mattick RP, Breen C, Kimber J, Davoli M. Methadone maintenance therapy versus opioid replacement therapy for opioid dependence. Cochrane Database Syst Rev. 2009:3:CD002209. doi:10.1002/14651858

Mattick RP, Kimber J, Breen C, Davoli M. Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Database Syst Rev. 2008:2:CD002207. doi:10.1002/14651858.

Miller WR, Rollnick S. Motivational Interviewing: Helping People Change. 3rd ed. New York, NY: Guilford Press; 2012.

National Institute on Alcohol Abuse and Alcoholism (NIAAA). Alcohol Screening and Brief Intervention for Youth: A Practitioner’s Guide. NIH Publication No. 11-7805. Bethesda, MD: NIAAA; 2015. Accessed June 22, 2016.

National Institute on Alcohol Abuse and Alcoholism (NIAAA). Underage Drinking. Bethesda, MD: NIAAA; n.d. Accessed June 22, 2016.

National Institute on Drug Abuse (NIDA). Principles of Adolescent Substance Use Disorder Treatment: A Research-Based Guide. NIH Pub. No. 14-7953. Bethesda, MD: NIDA; 2014. Accessed June 22, 2016.

Pbert L, Moolchan ET, Muramoto M, et al. The state of office-based intervention for youth tobacco use. Pediatrics. 2003;111(6):e650-e660.

Pitts S, Shrier LA. Substance abuse screening and brief intervention for adolescents in primary care. Pediatr Ann. 2014;43(10):e248–e252.

Subramaniam GA, Fishman MJ, Woody G. Treatment of opioid-dependent adolescents and young adults with buprenorphine. Current Psychiatry Reports. 2009;11(5):360-363.

Subramaniam GA, Levy S. Providers’ Clinical Support System for Medication Assisted Treatment: PCSS Guidance Treatment of Opioid-Dependent Adolescents and Young Adults Using Sublingual Buprenorphine. Rev.ed.; 2013. Accessed June 21, 2016.

Substance Abuse and Mental Health Services Administration (SAMHSA; a).Certification of Opioid Treatment Programs (OTPs). Rockville, MD: SAMHSA; 2015. Accessed September 2, 2016.

Substance Abuse and Mental Health Services Administration(SAMHSA; b).Clinical Use of Extended-Release Injectable Naltrexone in the Treatment of Opioid Use Disorder: A Brief Guide. Rockville, MD: SAMHSA; 2015. Accessed September 2, 2016.

Veliz P, Boyd C, McCabe SE. Adolescent athletic participation and nonmedical Adderall use: an exploratory analysis of a performance-enhancing drug. J Stud Alcohol Drugs. 2013;74(5):714-719. doi:10.15288/jsad.2013.74.714.

Wu P, Goodwin RD, Fuller C, et al. The relationship between anxiety disorders and substance use among adolescents in the community: specificity and gender differences. J Youth Adolesc.2010;39(2):177-188.

1